Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; the references it cites are not checked yet.

Weight loss and risk reduction of obesity-related outcomes in 0·5 million people: evidence from a UK primary care database

Open access
Haase, Christiane Lundegaard, Lopes, Sandra, Olsen, Anne Helene, Satylganova, Altynai, Schnecke, Volker, McEwan, Phil · 2021 · International Journal of Obesity

Abstract

High body mass index (BMI) is known to be associated with various conditions, including type 2 diabetes (T2D), osteoarthritis, cardiovascular disease (CVD) and sleep apnoea; however, the impact of intentional weight loss on the risk of these and other outcomes is not well quantified. We examined the effect of weight loss on ten selected outcomes in a population from the UK Clinical Practice Research Datalink (CPRD) GOLD database. Included individuals were >18 years old at the index date (first BMI value between January 2001 and December 2010). They were categorised by their weight pattern between year 1 post-index and year 4 post-index (baseline period) as having stable weight (−5% to +5%) or weight loss (−25% to −10%, plus evidence of intervention or dietary advice to confirm intention to lose weight). For inclusion, individuals also required a BMI of 25.0–50.0 kg/m 2 at the start of the follow-up period, during which the occurrence of ten obesity-related outcomes was recorded. Cox proportional hazard models adjusted for BMI, comorbidities, age, sex and smoking status were used to estimate relative risks for weight loss compared with stable weight. Individuals in the weight-loss cohort had median 13% weight loss. Assuming a BMI of 40 kg/m 2 before weight loss, this resulted in risk reductions for T2D (41%), sleep apnoea (40%), hypertension (22%), dyslipidaemia (19%) and asthma (18%). Furthermore, weight loss was associated with additional benefits, with lower risk of T2D, chronic kidney disease, hypertension and dyslipidaemia compared with maintaining the corresponding stable lower BMI throughout the study. This study provides objective, real-world quantification of the effects of weight loss on selected outcomes, with the greatest benefits observed for the established CVD risk factors T2D, hypertension and dyslipidaemia.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41366-021-00788-4

Cites

Statistics

Figures

Fig. 1 Study design and objectives. a Study design showing weight trajectories for the stable-weight (−5% to +5% BMI; orange), weight-loss cohorts (−25% to −10% BMI; blue) and corresponding stable lower BMI (grey). b Illustration of the comparisons made as part of objective 1 and objective 2 at the end of the follow-up period. c Example hazard ratio profiles (HRs and 95% CI) showing the comparative benefit patterns before weight loss (orange) with the risk after weight loss (blue) relative to the corresponding stable lower BMI (grey). aRecord indicating either a weight-loss diet, weight-loss drug prescription, or referral to a dietician or for bariatric surgery during the baseline period, to confirm the intention to lose weight; bDate of first BMI calculation. BMI body mass index, CI confidence interval, CKD chronic kidney disease, HR hazard ratio, MI myocardial infarction, T2D type 2 diabetes.
Fig. 1 Study design and objectives. a Study design showing weight trajectories for the stable-weight (−5% to +5% BMI; orange), weight-loss cohorts (−25% to −10% BMI; blue) and corresponding stable lower BMI (grey). b Illustration of the comparisons made as part of objective 1 and objective 2 at the end of the follow-up period. c Example hazard ratio profiles (HRs and 95% CI) showing the comparative benefit patterns before weight loss (orange) with the risk after weight loss (blue) relative to the corresponding stable lower BMI (grey). aRecord indicating either a weight-loss diet, weight-loss drug prescription, or referral to a dietician or for bariatric surgery during the baseline period, to confirm the intention to lose weight; bDate of first BMI calculation. BMI body mass index, CI confidence interval, CKD chronic kidney disease, HR hazard ratio, MI myocardial infarction, T2D type 2 diabetes.CC BY · PubMed Central
Fig. 2 Prevalence of baseline comorbidities. Bar chart showing the prevalence of comorbidities at baseline (i.e., the start of the follow-up period) in the stable-weight and weight-loss cohorts. CKD chronic kidney disease, CV cardiovascular, T2D type 2 diabetes.
Fig. 2 Prevalence of baseline comorbidities. Bar chart showing the prevalence of comorbidities at baseline (i.e., the start of the follow-up period) in the stable-weight and weight-loss cohorts. CKD chronic kidney disease, CV cardiovascular, T2D type 2 diabetes.CC BY · PubMed Central
Fig. 3 Risk profiles before and after weight loss for ten obesity-related outcomes (objective 1). Risk profiles and 95% CI (shaded area) showing the risk of outcomes before (dashed line) and after (solid line) weight loss. HRs are expressed relative to a stable BMI of 30 kg/m2. BMI body mass index, CI confidence interval, CKD chronic kidney disease, HR hazard ratio, MI myocardial infarction, T2D type 2 diabetes.
Fig. 3 Risk profiles before and after weight loss for ten obesity-related outcomes (objective 1). Risk profiles and 95% CI (shaded area) showing the risk of outcomes before (dashed line) and after (solid line) weight loss. HRs are expressed relative to a stable BMI of 30 kg/m2. BMI body mass index, CI confidence interval, CKD chronic kidney disease, HR hazard ratio, MI myocardial infarction, T2D type 2 diabetes.CC BY · PubMed Central
Fig. 4 Risk profile for median 13% weight loss for ten obesity-related outcomes (objective 2). Changes in outcome risks are plotted as the risk before (orange open circles) and after (blue closed circles) weight loss relative to the corresponding stable lower BMI (grey squares) for each BMI profile. BMI body mass index, CKD chronic kidney disease, HR hazard ratio, MI myocardial infarction, T2D type 2 diabetes.
Fig. 4 Risk profile for median 13% weight loss for ten obesity-related outcomes (objective 2). Changes in outcome risks are plotted as the risk before (orange open circles) and after (blue closed circles) weight loss relative to the corresponding stable lower BMI (grey squares) for each BMI profile. BMI body mass index, CKD chronic kidney disease, HR hazard ratio, MI myocardial infarction, T2D type 2 diabetes.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

The citation lists are queued

They are fetched later and appear here then.

References 32 · Cited by 199

Research works printed but not linked: 1

  1. OECD Health Policy Study. The heavy burden of obesity. 2019. https://www.oecd-ilibrary.org/docserver/67450d67-en.pdf?expires=1587545422&id=id&accname=guest&checksum=42A754049C8DD63B680DB0EC4EB5DC80. Accessed 22 Apr 2020.

Metadata

Authors
Haase, C. L., Lopes, S., Olsen, A. H., Satylganova, A., Schnecke, V., & McEwan, P.
Affiliations
  • Novo Nordisk (Denmark) (DK)
  • Health Economics and Outcomes Research (United Kingdom) (GB)
Corresponding author
Haase, Christiane Lundegaard
Venue
International Journal of Obesity
Published
2021-03-03
Volume
45
Issue
6
Pages
1249-1258
ISSN
  • 0307-0565 (ISSN-L)
  • 1476-5497
OpenAlex
W3134938531
Cited by
199
References
32
Citations by year
2026: 19 · 2025: 48 · 2024: 59 · 2023: 38 · 2022: 28 · 2021: 7
FWCI
28.53
Type
journal article
Language
en
Open access
Licence
Locations
  • International Journal of Obesity (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
Novo Nordisk
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Obesity, Physical Activity, Diet
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Obesity and Health Practices
Keywords
weight loss, obesity, body mass index, type 2 diabetes, sleep apnea, hypertension, dyslipidemia, chronic kidney disease, asthma, cardiovascular risk factors, primary care
MeSH terms
Adult, Diabetes Mellitus, Type 2, Female, United Kingdom, Humans, Hypertension, Male, Middle Aged, Obesity, Primary Health Care, Weight Loss, Comorbidity, Databases, Factual, Risk Reduction Behavior

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Weight loss and risk reduction of obesity-related outcomes in 0·5 million people: evidence from a UK primary care database. https://app.cochat.ai/papers/10.1038/s41366-021-00788-4
The paper
Haase, C. L., Lopes, S., Olsen, A. H., Satylganova, A., Schnecke, V., & McEwan, P. (2021). Weight loss and risk reduction of obesity-related outcomes in 0·5 million people: evidence from a UK primary care database. International Journal of Obesity. https://doi.org/10.1038/s41366-021-00788-4

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.